Programmed Death Ligand 1: A Poor Prognostic Marker in Endometrial Carcinoma

Endometrial carcinoma is the only gynaecologic malignancy with a raising incidence and mortality, posing a major health concern worldwide. The upregulation of programmed death ligand 1 (PD-L1) on tumour cells causes T-cell suppression, which impedes antitumour immunity, promotes immune cell evasion...

Descripción completa

Detalles Bibliográficos
Autores principales: Chew, Mianxin, Wong, Yin Ping, Karim, Norain, Mustangin, Muaatamarulain, Alfian, Nurwardah, Tan, Geok Chin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345287/
https://www.ncbi.nlm.nih.gov/pubmed/32545177
http://dx.doi.org/10.3390/diagnostics10060394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345287/
https://www.ncbi.nlm.nih.gov/pubmed/32545177
http://dx.doi.org/10.3390/diagnostics10060394

Ejemplares similares